NasdaqCM - Delayed Quote USD

Arcadia Biosciences, Inc. (RKDA)

2.9000 +0.2200 (+8.21%)
At close: May 15 at 4:00 PM EDT
2.8600 -0.04 (-1.38%)
After hours: May 15 at 7:42 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Stanley E. Jacot Jr. President, CEO & Director 515.16k -- 1971
Mr. Thomas J. Schaefer CFO & Corporate Secretary 359.45k -- 1976
Mr. Tracy Baker Senior Vice President of Seamless Technical Operations -- -- --

Arcadia Biosciences, Inc.

5950 Sherry Lane
Suite 215
Dallas, TX 75225
United States
214 974 8921 https://www.arcadiabio.com
Industry: 
Packaged Foods
Full Time Employees: 
21

Description

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

Corporate Governance

Arcadia Biosciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Aug 08, 2024 - Aug 12, 2024
Arcadia Biosciences, Inc. Earnings Call

Related Tickers